Articles related to CONTRACEPTION/BIRTH CONTROL

Updated recommendations emphasize same-day contraceptive provision with minimal examination requirements, focusing on adolescent-centered counseling that addresses individual reproductive health goals across pediatric and gynecologic practice settings.

This innovative intrauterine device may allow for improvements in discontinuation rates due to pain and bleeding and in expulsion rates.

A comprehensive analysis of 176,601 cancer cases demonstrates that long-acting reversible contraceptives offer a cancer risk profile comparable to oral contraceptives, with data showing a 20-30% reduction in gynecologic cancer risk and a modest increase in breast cancer risk that returns to baseline after cessation.

The court held that damages can extend to the long-term care of the child with special needs.

Long-acting reversible contraceptives show varying effects on cancer risk, with some methods demonstrating protective effects against certain cancers while increasing risks for others.

A national case-control study of 108,366 women found that prolonged use of injectable medroxyprogesterone acetate was associated with a 5.55-fold increased risk of intracranial meningioma requiring surgery (95% CI 2.27-13.56), while levonorgestrel IUDs showed no increased risk.